Abigail Reiter
Physician Assistant · Atkins, IANPI 1295277465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 535 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 29.0% of the total. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 535 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pfizer$683
- AstraZeneca$659
- Boehringer Ingelheim$586
- Lilly USA, LLC$546
- Amgen$488
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,638100%
- Education$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 150 | $2,516 |
| Pfizer | 39 | $683 |
| AstraZeneca | 33 | $659 |
| Boehringer Ingelheim | 38 | $586 |
| Lilly USA, LLC | 38 | $546 |
| Amgen | 42 | $488 |
| Bayer | 22 | $418 |
| Axsome Therapeutics, Inc. | 17 | $356 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $271 |
| Mylan Specialty L.p. | 14 | $218 |
| Otsuka America Pharmaceutical, Inc. | 11 | $209 |
| Novo Nordisk | 12 | $200 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $161 |
| Exact Sciences | 9 | $152 |
| Biohaven Pharmaceuticals, Inc. | 10 | $127 |
| Idorsia Pharmaceuticals US Inc | 8 | $122 |
| Phathom Pharmaceuticals, Inc. | 5 | $121 |
| Esperion Therapeutics, Inc. | 6 | $102 |
| Merck | 6 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $84 |
| GSK | 5 | $77 |
| Novartis | 4 | $70 |
| Amarin Pharma, Inc. | 4 | $68 |
| Paratek Pharmaceuticals, Inc. | 4 | $67 |
| Johnson & Johnson | 3 | $41 |
| Vertex | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Harmony Biosciences LLC | 1 | $30 |
| Eisai Inc. | 2 | $28 |
| Genentech USA, Inc. | 3 | $27 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$8,666 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $33,303 |
| MounjaroTirzepatide | 24 | $28,865 |
| JardianceEmpagliflozin | 39 | $27,928 |
| FarxigaDapagliflozin Propanediol | 30 | $27,000 |
| Repatha SureclickEvolocumab | 22 | $13,520 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,308 |
| EliquisApixaban | 16 | $13,003 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,701 |
| PremarinEstrogens, Conjugated | 13 | $2,646 |
| Gabapentin | 54 | $1,612 |
| Potassium Chloride | 53 | $1,599 |
| Ventolin HfaAlbuterol Sulfate | 16 | $1,146 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,025 |
| Omeprazole | 79 | $951 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $659 | $43,00963 claims |
| Novo NordiskOzempic | $200 | $33,30333 claims |
| Lilly USA, LLCMounjaro | $546 | $28,86524 claims |
| Boehringer IngelheimJardiance | $586 | $27,92839 claims |
| PfizerEliquis, Premarin | $683 | $15,65029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Atkins
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Kelly MerchieDavenport$15K
- Kathleen DuffyClive$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.